Orofacial non-Hodgkin's lymphoma in Nigerians

被引:6
作者
Ugboko, VI [1 ]
Oginni, FO
Adelusola, KA
Durosinmi, MA
机构
[1] Obafemi Awolowo Univ, Coll Hlth Sci, Fac Dent, Dept Oral & Maxillofacial Surg, Ife, Nigeria
[2] Obafemi Awolowo Univ, Coll Hlth Sci, Fac Dent, Dept Morbid Anat & Forens Med, Ife, Nigeria
[3] Obafemi Awolowo Univ, Coll Hlth Sci, Fac Dent, Dept Heamatol & Immunol, Ife, Nigeria
关键词
D O I
10.1016/j.joms.2004.07.003
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: In this study, we sought to determine the occurrence of primary non-Hodgkin's lymphoma (NHL) in the oral and maxillofacial region among Nigerians. Patients and Methods: we retrospectively studied hospital records that included radiographs of all patients with a histopathologically confirmed diagnosis of NHL in the Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria, between January 1992 and December 1997. Data were expressed as mean +/- SD or number (%). Results: During the study period, 66 cases of NEL were recorded. Seventeen patients had concomitant extranodal lymphomas involving the gastrointestinal tract, nasopharynx, skin, lungs, kidney, and thyroid, in descending order. Three patients (4.5%) presented primarily with extranodal oral and maxillofacial disease. The ages of these patients ranged from 18 to 50 years (mean +/- SD, 32.3 +/- 16.3 years; median, 29 years). Within the same period, there were 121 cases of Burkitt's lymphoma. The onset of lesions varied from 6 to 20 weeks. Two patients had intermediate-grade lesions; the remainder had low-grade lesions. Two presented with stage H disease, and the remainder were stage I. All of the patients had chemotherapy with remission of their lesions but were followed up to 6 months. Most of them did not complete the treatment cycles due to financial and social constraints. Conclusions: The rarity of primary NHL of oral and maxillofacial region has been aptly shown in this study. The need for the establishment of an effective oncology policy with the active collaboration of voluntary agencies is emphasized. This would ensure ready availability of the required chemotherapeutic agents and hospital care at affordable costs. (C) 2004 American Association of Oral and Maxillofacial Surgeons.
引用
收藏
页码:1347 / 1350
页数:4
相关论文
共 30 条
[1]  
Arican A, 1999, AM J CLIN ONCOL-CANC, V22, P587
[2]   Head and neck non Hodgkin's lymphomas [J].
Artese, L ;
DiAlberti, L ;
Lombardo, M ;
Liberatore, E ;
Piattelli, A .
ORAL ONCOLOGY, 1995, 31B (05) :299-300
[3]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[4]  
Donato V, 1998, ANTICANCER RES, V18, P547
[5]  
DUROSINMI MA, 1993, NIGERIAN MED J, V25, P92
[6]  
DUROSINMI MA, 1998, DESIGN HDB HAEMATO O, P6
[7]  
Economopoulos T, 1998, ANTICANCER RES, V18, P4655
[8]   ORAL PRESENTATIONS IN NON-HODGKINS LYMPHOMA - A REVIEW OF THIRTY-ONE CASES .1. DATA-ANALYSIS [J].
EISENBUD, L ;
SCIUBBA, J ;
MIR, R ;
SACHS, SA .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1983, 56 (02) :151-156
[9]   Localized non-Hodgkin's lymphoma of Waldeyer's ring: Clinical features, management, and prognosis of 130 adult patients [J].
Ezzat, AA ;
Ibrahim, EM ;
El Weshi, AN ;
Khafaga, YM ;
AlJurf, M ;
Martin, JM ;
Ajarim, DS ;
Bazarbashi, SN ;
Stuart, RK ;
Zucca, E .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (07) :547-558
[10]  
Hanna E, 1997, ARCH OTOLARYNGOL, V123, P1318